Drug details
Inbrija (levodopa inhalation powder)
type of Antiparkinson Agents, Dopamine Precursors
Inbrija (levodopa inhalation powder) is an aromatic amino acid indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with
carbidopa/levodopa.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- lightheadedness,
- confusion,
- wheezing,
- sweating,
- agitation,
- trouble sleeping,
- aggression,
- hallucinations,
- paranoia,
- chest tightness,
- unusual thoughts or behavior,
- increased sexual urges,
- extreme drowsiness,
- trouble breathing after using the medication,
- falling asleep suddenly,
- increased dreaming,
- unusual urges to gamble,
- other intense urges, and
- falling asleep while normal daytime activities (working, talking, eating, or driving)
The following drugs are related to Inbrija, either as a replacement or used together:
- Gocovri (amantadine extended release capsules, for oral use)
- Symmetrel (amantadine hydrochloride)
- Apokyn (apomorphine)
- Kynmobi (apomorphine hydrochloride sublingual film)
- Artane (trihexyphenidyl)
- Azilect (rasagiline)
- Cogentin (benztropine mesylate injection)
- Rytary (carbidopa and levodopa capsules)
- Duopa (carbidopa and levodopa enteral suspension)
- Parcopa (carbidopa and levodopa extended-release tablets)
- Dhivy (carbidopa and levodopa tablets)
- Stalevo (carbidopa, levodopa and entacapone)
- Sinemet (carbidopa-levodopa)
- Sinemet CR (carbidopa-levodopa sustained release)
- Comtan (entacapone)
- Eldepryl (selegiline hcl)
- Nourianz (istradefylline tablets)
- Mirapex (pramipexole)
- Mirapex ER (pramipexole dihydrochloride extended-release tablets)
- Neupro (rotigotine transdermal system)
- Ongentys (opicapone capsules)
- Requip (ropinirole hcl)
- Requip XL (ropinirole extended release tablets)
- Xadago (safinamide tablets)
- Zelapar (selegiline hydrochloride)
- Tasmar (tolcapone)